Immunome Inc. share price logo

Immunome Inc.

NASDAQ: IMNM

Mid Cap

$22.29

+0.09

(+0.41%)

Live

as on

Immunome Inc. Stock Performance

as on July 18, 2026 at 6:16 am IST

  • Day's Low

    Day's High

    $21.59
    $22.91
    downward going graph

    3.14%

    Downside

    2.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.67
    $27.65
    downward going graph

    61.13%

    Downside

    24.05%

    Upside

    downward going graph

Immunome Inc. share price movements today

Previous Close
$22.20
Open
$21.70
Volume
328.5K
Day's Low - High
$21.59 - $22.91
52 Week Low - High
$8.67 - $27.65

Immunome Inc. Historical Returns

1 Month Return
+ 18.46 %
3 Month Return
-9.87 %
1 Year Return
+ 109.83 %
3 Year Return
+ 186.45 %
5 Year Return
+ 43.04 %

Immunome Inc. Stock Fundamentals & Key Indicators

Check Immunome Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.6B

EPS (TTM)

-2.1247

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-226.3M

Revenue (TTM)

4.0M

Profit Margin

0.00%

Return On Equity TTM

-50.14%

Immunome Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunome Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Immunome Inc. image
Immunome Inc.
BUY$2.6B43.04%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.2B501.07%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$122.9B140.28%28.7635.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$71.2B16.41%16.5929.65%0.54%

Stock Returns calculator for Immunome Inc. Stock including INR - Dollar returns

The Immunome Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Immunome Inc. investment value today

Current value as on today

₹2,35,744

Returns

₹1,35,744

(+135.74%)

Returns from Immunome Inc. Stock

₹1,10,681 (+110.68%)

Dollar Impact

₹25,063 (+25.06%)

Analyst Recommendation on Immunome Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Immunome Inc.. Average target price of $35.77

Immunome Inc. Share Price Target

Get share price movements and forecasts by analysts on Immunome Inc..

What analysts predicted

37.69%UPSIDE

Target Price

$35.77

Current Price

$22.29

Analyzed by

11 Analysts

Target

$35.77

Immunome Inc. target price $35.77, a slight upside of 37.69% compared to current price of $22.29. According to 11 analysts rating.

Indian Investors' Interest in Immunome Inc. Stock

Search interest for Immunome Inc. Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:64% versus previous 30 day period

Immunome Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
3
1
2
2
2
2
4
-
-
-
Gross Profit
3
1
2
2
2
2
3
-49
0
0
Operating Income
-94
-132
-40
-50
-82
-44
-46
-60
-72
-59
EBITDA
-13
-20
-33
-43
-55
-40
-42
-56
-69
-53
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-92
-129
-36
-47
-80
-41
-43
-57
-69
-53
Income Tax Expense
0
0
-
-
-
-
-
-
-
-
Net Income
-92
-129
-36
-47
-80
-41
-43
-57
-69
-53
Net Profit Margin
-2421.17%
-12584.26%
-1528.00%
-1618.56%
-2930.93%
-1423.10%
-1080.87%
0.00%
0.00%
0.00%

Immunome Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
6
14
9
6
Gross Profit
0
0
0
0
0
14
9
3
Operating Income
-7
-10
-12
-25
-36
-109
-305
-214
EBITDA
-7
-9
-11
-23
-36
-28
-151
-209
Interest Expense
0
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
2
2
Income Before Tax
-7
-10
-17
-24
-36
-106
-292
-212
Income Tax Expense
0
0
0
0
0
0
-292
-
Net Income
-7
-10
-17
-24
-36
-106
-292
-212
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-556.75%
-761.92%
-3240.38%
-3059.99%

Immunome Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-129
-36
-47
-80
-41
-43
-57
-69
-53
Operating Cash Flow
-11
-23
-34
-42
-53
-49
-40
-47
-58
Investing Cash Flow
-37
-81
24
9
5
-64
123
-3
-12
Financing Cash Flow
219
0
0
20
162
0
45
432
0
Change in Cash
171
-104
-9
-12
114
-113
128
380
-70

Immunome Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-17
-24
-36
-106
-292
-212
Operating Cash Flow
-9
-12
-18
-28
-7
-110
-190
Investing Cash Flow
0
0
0
0
-30
-85
60
Financing Cash Flow
10
49
27
0
116
240
640
Change in Cash
0
37
9
-28
78
44
510

Global Institutional Holdings in Immunome Inc.

Funds
Holdings
FMR Inc
14.98%
T. Rowe Price Associates, Inc.
2.52%
SILVERARC CAPITAL MANAGEMENT, LLC
1.63%
EcoR1 Capital, LLC
2.52%
State Street Corp
4.77%
See all

Immunome Inc. News & Key Events

  • img

    Today's Timeline - 08 July

    Wed, 05:00 PM

    -

    Immunome announces FDA acceptance of NDA for varegacestat to treat adults with desmoid tumors, with a PDUFA date of April 28, 2027.

Insights on Immunome Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, IMNM stock has moved up by 19.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 358.8% return, outperforming this stock by 246.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 573.4% return, outperforming this stock by 387.7%

About Immunome Inc.

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
OrganisationImmunome Inc.
Headquarters18702 North Creek Parkway, Bothell, WA, United States, 98011
IndustryBiotechnology
CEODr. Clay B. Siegall Ph.D.
E-voting on sharesClick here to vote

Key Management of Immunome Inc.

Name

Title

Dr. Robert J. Lechleider M.D.

Chief Medical Officer

Dr. Philip Tsai

Chief Technical Officer

Dr. Jack Higgins Ph.D.

Chief Scientific Officer

Ms. Sandra G. Stoneman Esq., J.D.

Chief Legal Officer, General Counsel & Corporate Secretary

Mr. Kinney Horn

Chief Business Officer

Mr. Roee Shahar

Executive Vice President of Commercial

Dr. Clay B. Siegall Ph.D.

Chairman, President & CEO

Mr. Max Rosett

Chief Financial Officer

FAQs

What is Immunome Inc. share price today?

Immunome Inc. share price today is $22.29 as on . Immunome Inc. share today touched a day high of $22.91 and a low of $21.59.

What is the 52 week high and 52 week low for Immunome Inc. share?

Immunome Inc. share touched a 52 week high of $27.65 on and a 52 week low of $8.67 on . Immunome Inc. stock price today i.e. is trending at $22.29,which is 19.39% down from its 52 week high and 157.24% up from its 52 week low.

What is Immunome Inc.'s market capitalisation today?

Immunome Inc. market capitalisation is $0.00T as on .

How to invest in Immunome Inc. Stock (IMNM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunome Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunome Inc. Shares that will get you 0.0673 shares as per Immunome Inc. share price of $22.29 per share as on July 18, 2026 at 12:46 am IST.

What is the minimum amount required to buy Immunome Inc. Stock (IMNM) from India?

Indian investors can start investing in Immunome Inc. (IMNM) shares with as little as ₹96.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.70 in Immunome Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunome Inc. share’s latest price of $22.29 as on July 18, 2026 at 12:46 am IST, you will get 0.4486 shares of Immunome Inc.. Learn more about fractional shares .

What are the returns that Immunome Inc. has given to Indian investors in the last 5 years?

Immunome Inc. stock has given 43.04% share price returns and 28.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?